5Ohkubo Y, Kishikawa H. Intensive insulin treatment prevents the progression of diabetic microvascular complications in Japanese patients with non - insulin dependent diabetes mellitus: A randomized prospective 6 year study[J]. Diabetes Res Clin Pract, 199
6UKPDS. Tight blood pressure control and risk of macrovascular and microvascular complications in NIDDM UKPDS38[J]. Br Med J, 1998,(317) :703.
7Betteridge D. Cholesterol is the major atherogenic lipid in NIDDM[J].Diabetes Metab Rev, 1997, (13):99.
8Wanner C. Lipids and progression of renal disease: role of modified LDLand lip oprotein[ J]. Kidey Int, 1997, (63): 10.
9Wang L, Yamaguchi T. A case - control study of risk factors for development of type 2 type 2 diabetes. Emphasis on physical activety[ J]. Epdemiol,2002,12(6) :424.
10Standl E, Stiegler H. Microalbuminuria in a random cohort of recently diagnosed Type 2 diabetic patients living in the Greater Munich are[J]. Diabetologia, 1993, (36): 1007.
